MEDLEY, Fla. (AP) — Sabrina Ionescu will not play in the second season of Unrivaled because of an injury sustained during the WNBA season.
The 3-on-3 women’s basketball league, which began its second season on Monday, announced the news Thursday, saying that Ionescu will still be involved with off-court initiatives and partnership opportunities.
The four-time WNBA All-Star with the New York Liberty played for Phantom BC during Unrivaled’s first season and averaged 18.2 points and seven rebounds.
“While I’m disappointed I couldn’t play this season, I’ll be rooting for the Phantom,” Ionescu said in a statement. “I’m looking forward to working with Unrivaled through content and broadcast opportunities and continuing to support the league’s success.”
Ionescu joined Napheesa Collier as stars who have been ruled out for Unrivaled’s second season. Collier, an Unrivaled co-founder and the league’s 2025 MVP, was set to have surgery on both of her ankles and will be sidelined four-to-six months.
___
AP WNBA: apnews.com/hub/wnba-basketball
Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Sabrina Ionescu sidelined for Unrivaled’s 2nd season due to injury WHEC.com.
Hence then, the article about sabrina ionescu sidelined for unrivaled s 2nd season due to injury was published today ( ) and is available on News10NBC ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Sabrina Ionescu sidelined for Unrivaled’s 2nd season due to injury )
Also on site :
- Anthropic adds Allianz to growing list of enterprise wins
- Robbie G.K. on ‘Heated Rivalry’ Impact on the NHL and Miley Cyrus Contributing Music to Season 2: ‘I Was Absolutely a “Hannah Montana” Fan’
- Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology